Tilray, Inc. (TLRY) Misses Q1 EPS by $1.31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
Tilray, Inc. Reports First Quarter 2020 Financial Results
May 11, 2020 4:05 PM EDTQuarterly Revenue Increased 126% to $52.1 Million (C$70.7 Million) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019
International Medical Cannabis Sales Exceeded Canada Medical Sales by 43% in the Quarter
Implemented Cost Reductions Designed to Achieve Approximately $40 Million Annualized Savings
Reduced Net Loss by $35 Million, or 16%, Compared to the Fourth Quarter of 2019
Implemented COVID-19 Related Protocols to Ensure the Health of Our Global Workforce and Satisfy Patient and Consumer Needs
Focused on Achieving Positive Adjusted EBITDA by End of the Fourth Quarter of 2020
NANAIMO, British... More
